EMA Authorizes Hemophilia B Gene Therapy ...Middle East

The European Medicines Agency has given the go-ahead for Durveqtix to treat hemophilia B in adults and to Adzynma for patients with congenital thrombotic thrombocytopenic purpura. Medscape Medical News

Hence then, the article about ema authorizes hemophilia b gene therapy was published today ( Friday 31/05/2024 - 07:12 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Authorizes Hemophilia B Gene Therapy )

Also on site :

• China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
• Prominent Canadian Musician Says Gig Was Cancelled After Google AI Overview Wrongly Branded Him Sex Pest
• Goldman Sachs expects layoffs to keep rising—and says investors are punishing the stocks of companies that slash staff